547 related articles for article (PubMed ID: 31465555)
1. The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols.
Man AWC; Xia N; Daiber A; Li H
Br J Pharmacol; 2020 Mar; 177(6):1278-1293. PubMed ID: 31465555
[TBL] [Abstract][Full Text] [Related]
2. Nutraceuticals as modulators of gut microbiota: Role in therapy.
Quigley EMM
Br J Pharmacol; 2020 Mar; 177(6):1351-1362. PubMed ID: 31659751
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism.
Man AWC; Zhou Y; Xia N; Li H
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33036205
[TBL] [Abstract][Full Text] [Related]
4. Microbiota-dependent and -independent effects of dietary fibre on human health.
Cai Y; Folkerts J; Folkerts G; Maurer M; Braber S
Br J Pharmacol; 2020 Mar; 177(6):1363-1381. PubMed ID: 31663129
[TBL] [Abstract][Full Text] [Related]
5. Bioactive polyphenols and cardiovascular disease: chemical antagonists, pharmacological agents or xenobiotics that drive an adaptive response?
Goszcz K; Duthie GG; Stewart D; Leslie SJ; Megson IL
Br J Pharmacol; 2017 Jun; 174(11):1209-1225. PubMed ID: 28071785
[TBL] [Abstract][Full Text] [Related]
6. The relationship between host circadian rhythms and intestinal microbiota: A new cue to improve health by tea polyphenols.
Song D; Yang CS; Zhang X; Wang Y
Crit Rev Food Sci Nutr; 2021; 61(1):139-148. PubMed ID: 31997655
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological basis and new insights of resveratrol action in the cardiovascular system.
Cheng CK; Luo JY; Lau CW; Chen ZY; Tian XY; Huang Y
Br J Pharmacol; 2020 Mar; 177(6):1258-1277. PubMed ID: 31347157
[TBL] [Abstract][Full Text] [Related]
8. Highlights into the pharmacology of nutraceuticals.
Andrew R; Izzo AA
Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Tea Polyphenols and Intestinal Microbiota in Host Metabolic Diseases from the Perspective of the Gut-Brain Axis.
Yan R; Ho CT; Zhang X
Mol Nutr Food Res; 2020 Jul; 64(14):e2000187. PubMed ID: 32506625
[TBL] [Abstract][Full Text] [Related]
10. Mediterranean diet and health status: Active ingredients and pharmacological mechanisms.
Schwingshackl L; Morze J; Hoffmann G
Br J Pharmacol; 2020 Mar; 177(6):1241-1257. PubMed ID: 31243760
[TBL] [Abstract][Full Text] [Related]
11. Drug-gut microbiota interactions: implications for neuropharmacology.
Walsh J; Griffin BT; Clarke G; Hyland NP
Br J Pharmacol; 2018 Dec; 175(24):4415-4429. PubMed ID: 29782640
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.
Kiouptsi K; Reinhardt C
Br J Pharmacol; 2018 Dec; 175(24):4439-4449. PubMed ID: 30129122
[TBL] [Abstract][Full Text] [Related]
13. Interactions of gut microbiota with dietary polyphenols and consequences to human health.
Tomás-Barberán FA; Selma MV; Espín JC
Curr Opin Clin Nutr Metab Care; 2016 Nov; 19(6):471-476. PubMed ID: 27490306
[TBL] [Abstract][Full Text] [Related]
14. Dietary polyphenol impact on gut health and microbiota.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2021; 61(4):690-711. PubMed ID: 32208932
[TBL] [Abstract][Full Text] [Related]
15. Role of dietary polyphenols on gut microbiota, their metabolites and health benefits.
Mithul Aravind S; Wichienchot S; Tsao R; Ramakrishnan S; Chakkaravarthi S
Food Res Int; 2021 Apr; 142():110189. PubMed ID: 33773665
[TBL] [Abstract][Full Text] [Related]
16. Dietary antioxidants remodel DNA methylation patterns in chronic disease.
Beetch M; Harandi-Zadeh S; Shen K; Lubecka K; Kitts DD; O'Hagan HM; Stefanska B
Br J Pharmacol; 2020 Mar; 177(6):1382-1408. PubMed ID: 31626338
[TBL] [Abstract][Full Text] [Related]
17. Polyphenol and Tannin Nutraceuticals and Their Metabolites: How the Human Gut Microbiota Influences Their Properties.
Fabbrini M; D'Amico F; Barone M; Conti G; Mengoli M; Brigidi P; Turroni S
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883431
[TBL] [Abstract][Full Text] [Related]
18. The role of gut microbiota in cerebrovascular disease and related dementia.
Cuartero MI; García-Culebras A; Nieto-Vaquero C; Fraga E; Torres-López C; Pradillo J; Lizasoain I; Moro MÁ
Br J Pharmacol; 2024 Mar; 181(6):816-839. PubMed ID: 37328270
[TBL] [Abstract][Full Text] [Related]
19. Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals.
Williamson EM; Liu X; Izzo AA
Br J Pharmacol; 2020 Mar; 177(6):1227-1240. PubMed ID: 31799702
[TBL] [Abstract][Full Text] [Related]
20. Biochemistry of Amaranthus polyphenols and their potential benefits on gut ecosystem: A comprehensive review of the literature.
Kongdang P; Dukaew N; Pruksakorn D; Koonrungsesomboon N
J Ethnopharmacol; 2021 Dec; 281():114547. PubMed ID: 34425138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
